Aix-en-Provence, Provence-Alpes-Côte d’Azur, France
Coordonnées
2 k abonnés
+ de 500 relations
Activité
-
I'm excited and proud to be part of a team focused on our company mission of developing solutions that improve lives impacted by kidney disease.
I'm excited and proud to be part of a team focused on our company mission of developing solutions that improve lives impacted by kidney disease.
Aimé par Sebastien Ladet, Ph.D.
-
This week my award came in the mail for 'FY24 Best Functional Support Partner' within Medtronic Surgical Innovations. 🤩 Strategy is important, but…
This week my award came in the mail for 'FY24 Best Functional Support Partner' within Medtronic Surgical Innovations. 🤩 Strategy is important, but…
Aimé par Sebastien Ladet, Ph.D.
-
🚀Huge news in the cardiac device space 💰Edwards Lifesciences continues its strategic expansion with two major acquisitions totalling $1.2 billion:…
🚀Huge news in the cardiac device space 💰Edwards Lifesciences continues its strategic expansion with two major acquisitions totalling $1.2 billion:…
Aimé par Sebastien Ladet, Ph.D.
Publications
-
Large pore size and controlled mesh elongation are relevant predictors for mesh integration quality and low shrinkage
International Journal of Surgery
Prosthetic mesh implants in hernia repair are frequently used based on the fact that lower recurrence rates are detected. However, an undesirable side effect is persistent foreign body reaction that drives adhesions and shrinkage among other things in the course of time. Thereby a variety of meshes have been created in an attempt to alleviate these side effects, and particular relating to shrinkage, the ideal mesh has not been developed. Large pore size is one of the properties to get better…
Prosthetic mesh implants in hernia repair are frequently used based on the fact that lower recurrence rates are detected. However, an undesirable side effect is persistent foreign body reaction that drives adhesions and shrinkage among other things in the course of time. Thereby a variety of meshes have been created in an attempt to alleviate these side effects, and particular relating to shrinkage, the ideal mesh has not been developed. Large pore size is one of the properties to get better ingrowth of the implants but could also be a risk factor to shrinkage behavior. The aim of this preclinical study was to determine optimal pore size based on mesh integration and shrinkage in a hernia minipig model
Other authors -
Multi-membrane chitosan hydrogels as chondrocytic cell bioreactors
Biomaterials
We investigated the bioactivity of new chitosan-based multi-membrane hydrogel (MMH) architectures towards chondrocyte-like cells. The microstructure of the hydrogels constituting the membranes precludes any living cell penetration, whereas their lower scale architecture allows the protein diffusion. The biological behavior of chondrocytes implanted within the MMH inter-membrane spaces was studied for 45 days in culture. Chondrocytes formed cell aggregates and proliferated without loosing their…
We investigated the bioactivity of new chitosan-based multi-membrane hydrogel (MMH) architectures towards chondrocyte-like cells. The microstructure of the hydrogels constituting the membranes precludes any living cell penetration, whereas their lower scale architecture allows the protein diffusion. The biological behavior of chondrocytes implanted within the MMH inter-membrane spaces was studied for 45 days in culture. Chondrocytes formed cell aggregates and proliferated without loosing their chondrogenic phenotype as illustrated by collagen II and aggrecan expressions at the mRNA and protein levels. Cells produced neo-formed alcyan blue matrix proteins filling MMH interspaces. The HiF-2a/ SOX9 pattern of expression suggested that the elevated chondrocytic phenotype in MMH could be related to a better hypoxic local environment than in classical culture conditions. Pro-inflammatory markers were not expressed during the period of culture. The low level of nitric oxide accumulation within the inter-membrane spaces and in the incubation medium implied that chitosan consumed nitrites produced by entrapped chondrocytes, in relation with the decrease of its molecular weight of 50%. Our data suggest that MMH structures may be considered as complex chondrocytic cell bioreactors; “active decoys of biological media”, potentially promising for various biomedical applications like the inter-vertebral disk replacement.
Other authors -
Multi-membrane hydrogels
Nature
Polysaccharide-based hydrogels are useful for numerous applications, from food1 and cosmetic processing to drug delivery and tissue engineering2, 3. The formation of hydrogels from polyelectrolyte solutions is complex, involving a variety of molecular interactions. The physical gelation of polysaccharides can be achieved by balancing solvophobic and solvophilic interactions4. Polymer chain reorganization can be obtained by solvent exchange, one of the processing routes forming a simple hydrogel…
Polysaccharide-based hydrogels are useful for numerous applications, from food1 and cosmetic processing to drug delivery and tissue engineering2, 3. The formation of hydrogels from polyelectrolyte solutions is complex, involving a variety of molecular interactions. The physical gelation of polysaccharides can be achieved by balancing solvophobic and solvophilic interactions4. Polymer chain reorganization can be obtained by solvent exchange, one of the processing routes forming a simple hydrogel assembly. Nevertheless, many studies on hydrogel formation are empirical with a limited understanding of the mechanisms involved, delaying the processing of more complex structures. Here we use a multi-step interrupted gelation process in controlled physico-chemical conditions to generate complex hydrogels with multi-membrane ‘onion-like’ architectures. Our approach greatly simplifies the processing of gels with complex shapes and a multi-membrane organization. In contrast with existing assemblies described in the literature, our method allows the formation of free ‘inter-membrane’ spaces well suited for cell or drug introduction. These architectures, potentially useful in biomedical applications, open interesting perspectives by taking advantage of tailor-made three-dimensional multi-membrane tubular or spherical structures.
Other authors
Brevets
-
FUNCTIONALIZED SURGICAL ADHESIVES
Émis le US US20090154378P
A bioadherent composition includes a first mixture containing a plurality of reactive members of a specific binding pair, said reactive members being bound to a ligand capable of binding a receptor on biological tissue, and a second mixture containing a plurality of complementary reactive members of the specific binding pair, said complementary reactive members being bound to a ligand capable of binding a receptor on biological tissue, said reactive members capable of forming covalent bonds…
A bioadherent composition includes a first mixture containing a plurality of reactive members of a specific binding pair, said reactive members being bound to a ligand capable of binding a receptor on biological tissue, and a second mixture containing a plurality of complementary reactive members of the specific binding pair, said complementary reactive members being bound to a ligand capable of binding a receptor on biological tissue, said reactive members capable of forming covalent bonds with said complementary reactive members via a reaction selected from Huisgen cycloaddition reactions, Diels-Alder reactions, and/or thiol-alkene reactions. A method for bonding biological tissue involves utilizing the bioadherent composition.
-
SELF-ASSEMBLING FIBROUS NETWORKS
Émis le US US20090154372P
The present invention relates to a kit comprising : - a plurality of fibers which have a plurality of reactive members of a primary specific binding pair attached to a surface of the fibers, and - a container adapted to contain a mixture including complementary reactive members of the primary specific binding pair, the complementary reactive members having a functionality that will adhere them to biological tissue upon contact.
-
MEDICAL DEVICE WITH DEGRADATION-RETARDING COATING
Émis le US WO2010095044
The present disclosure relates to implantable bioabsorbable medical devices having an amphiphilic coating for delaying the degradation of the device and methods of making such devices.
-
MEDICAL DEVICES INCORPORATING FUNCTIONAL ADHESIVES
Émis le US US20090154367P
The invention relates to a kit comprising: - a polymeric medical device having a plurality of reactive members of a specific binding pair attached to a surface of the device; and a container containing a mixture including complementary reactive members of the specific binding pair, the complementary reactive members having a functionality adapted to adhere them to biological tissue upon contact.
-
FUNCTIONALIZED ADHESIVE MEDICAL GEL
Émis le US US20090154369P
The present invention relates to a kit comprising: - a medical gel having a plurality of reactive members of a specific binding pair adapted to be attached on a surface of the gel; and - a container containing a mixture including complementary reactive members of the specific binding pair, the complementary reactive members having a functionality that will adhere them to biological tissue upon contact. The invention further relates to a bioadherent substrate including such a medical gel and to…
The present invention relates to a kit comprising: - a medical gel having a plurality of reactive members of a specific binding pair adapted to be attached on a surface of the gel; and - a container containing a mixture including complementary reactive members of the specific binding pair, the complementary reactive members having a functionality that will adhere them to biological tissue upon contact. The invention further relates to a bioadherent substrate including such a medical gel and to a method of forming such a medical gel.
-
MEDICAL DEVICES WITH DEFINABLE POROSITY PRODUCED BY BACTERIAL POLYMER BIO-SYNTHESIS
Émis le US US20080112295P
The present invention relates to a method of forming an implantable medical device comprising: culturing polymer-producing bacteria preferably Acetobacter xylinum in the presence of a degradable support; and removing the degradable support to recover an implant having pores of a configuration determined at least in part by the configuration of the degradable support. The invention also relates to a medical device obtained by such a method.
-
AUTO-SEALANT MATRIX FOR TISSUE REPAIR
Émis le US US20080196544P
Implants for tissue repair/regeneration include a porous layer combined with dry materials that are activated to form a hydrogel upon contact with aqueous physiological fluids.
-
MATRIX FOR TISSUE REPAIR
Émis le US US20080196487P
Implants include a porous layer made from a composition including a compound wherein collagen is cross-linked to a glycosaminoglycan, the porous layer being optionally joined to a collagen film.
-
Bioresorbable and biocompatible compounds for surgical use
Émis le US US20070899694
A bioresorbable and biocompatible compound for surgical use is composed of functionalized collagen cross-linked with a glycosaminoglycan.
-
DURAL REPAIR MATERIAL
Émis le US WO2009022230
Multilayer structures including a porous layer and a non-porous layer having a reinforcement member are useful as dural repair materials.
-
MULTIPLE-MEMBRANE POLYSACCHARIDE CAPSULES
Émis le FR WO2006092540
The invention concerns a method for preparing multiple-membrane capsules formed by a series of non-integral membranes and consisting of a common ionizable polysaccharide, in the form of a physical hydrogel, including the following steps: a) forming an ionizable polysaccharide physical hydrogel, in cationic or anionic form, in a mold with shape adapted to the shape desired for the capsule; b) immersing the hydrogel into an alkali solution in the case of a cationic polysaccharide, or an acid…
The invention concerns a method for preparing multiple-membrane capsules formed by a series of non-integral membranes and consisting of a common ionizable polysaccharide, in the form of a physical hydrogel, including the following steps: a) forming an ionizable polysaccharide physical hydrogel, in cationic or anionic form, in a mold with shape adapted to the shape desired for the capsule; b) immersing the hydrogel into an alkali solution in the case of a cationic polysaccharide, or an acid solution in the case of an anionic polysaccharide, for a given immersion time, then allowing it to rest outside the solution for a given resting time, so as to obtain a first membrane; c) repeating step b, as many times as the desired number of additional membranes, to form successive membranes from outside inwards of the capsule.
Prix et distinctions
-
President's award Surgical Devices - Covidien: 2010
Surgical Devices
-
Braconnot Prize
European Chitin Society
The Braconnot Prize is awarded for outstanding contributions and achievements in chitin science and for special merits in the promotion of EUCHIS. - See more at: http://euchis.org/#sthash.sAcpyJI0.dpuf
http://euchis.org/previous-winners-of-the-braconnot-prize/
Langues
-
Français
Bilingue ou langue natale
-
Anglais
Capacité professionnelle générale
-
Espagnol
Notions
Plus d’activités de Sebastien
-
One of the best parts of my current role at Medtronic has been traveling the globe to meet some of the smartest people who are making the most…
One of the best parts of my current role at Medtronic has been traveling the globe to meet some of the smartest people who are making the most…
Aimé par Sebastien Ladet, Ph.D.
-
On parle souvent des 3P d’une entreprise durable : People, Planet, Profit. Certains les mettent dans un autre ordre : Planet, People, Profit. Peu…
On parle souvent des 3P d’une entreprise durable : People, Planet, Profit. Certains les mettent dans un autre ordre : Planet, People, Profit. Peu…
Aimé par Sebastien Ladet, Ph.D.
-
It was a pleasure to visit Professor Zdravko Perko and the team at KBC Split in Croatia a few weeks ago with our Robotics Customer Success & Field…
It was a pleasure to visit Professor Zdravko Perko and the team at KBC Split in Croatia a few weeks ago with our Robotics Customer Success & Field…
Aimé par Sebastien Ladet, Ph.D.
-
Une flamme sans combustible, faite d’eau et de lumière, qui ne brûle pas mais qui illumine. C’est une première, signée EDF. Avec son anneau-flamme…
Une flamme sans combustible, faite d’eau et de lumière, qui ne brûle pas mais qui illumine. C’est une première, signée EDF. Avec son anneau-flamme…
Aimé par Sebastien Ladet, Ph.D.
-
🎥 Grâce à une offre éditoriale de 340 vidéos par mois, constituée de sujets d'actualité, de reportages et de séries originales, Le Parisien s’est…
🎥 Grâce à une offre éditoriale de 340 vidéos par mois, constituée de sujets d'actualité, de reportages et de séries originales, Le Parisien s’est…
Aimé par Sebastien Ladet, Ph.D.
-
Retrouvez-moi p 66 de Capital Magazine ! Dans son dossier "la France en 2040", le magazine présente les "innovations qui vont réveiller la France"…
Retrouvez-moi p 66 de Capital Magazine ! Dans son dossier "la France en 2040", le magazine présente les "innovations qui vont réveiller la France"…
Aimé par Sebastien Ladet, Ph.D.
-
🔆 A vitamin-packed breakfast for an energetic team at Affluent Medical 🔆 At Affluent Medical, we're always going 100 miles an hour to improve the…
🔆 A vitamin-packed breakfast for an energetic team at Affluent Medical 🔆 At Affluent Medical, we're always going 100 miles an hour to improve the…
Aimé par Sebastien Ladet, Ph.D.
-
🤩 HISTORIQUE ! 🔵⚪🔴 Nantenin KEITA et Alexis HANQUINQUANT, les deux porte-drapeaux des Jeux Paralympiques, accompagnés de la championne…
🤩 HISTORIQUE ! 🔵⚪🔴 Nantenin KEITA et Alexis HANQUINQUANT, les deux porte-drapeaux des Jeux Paralympiques, accompagnés de la championne…
Aimé par Sebastien Ladet, Ph.D.
-
Liberté, Égalité, Fraternité. Fierté.
Liberté, Égalité, Fraternité. Fierté.
Aimé par Sebastien Ladet, Ph.D.
-
“Where do you come from?” Since the age of 18, I have spent 1 year in Nepal, 2 years in Hong Kong, 3 years in Singapore, 5 years in the UK, 9 years…
“Where do you come from?” Since the age of 18, I have spent 1 year in Nepal, 2 years in Hong Kong, 3 years in Singapore, 5 years in the UK, 9 years…
Aimé par Sebastien Ladet, Ph.D.
-
Elle a 36 ans, une application et 10 salariés. Et elle fait trembler l'industrie agroalimentaire : C’est Julie Chapon, la cofondatrice de…
Elle a 36 ans, une application et 10 salariés. Et elle fait trembler l'industrie agroalimentaire : C’est Julie Chapon, la cofondatrice de…
Aimé par Sebastien Ladet, Ph.D.
Autres profils similaires
-
Celine Roger-Dalbert
Se connecter -
Bérangère GRANGER
President at Meyeboutique LLC DBA Belleair Opticians
Se connecter -
Bernard Brosset Heckel
Plant Manager
Se connecter -
Patrick KHALIFE
Se connecter -
Loucif Ouyahia
Global Digital Healthcare | Digital New Era | Innovation | Disruption | Accessibility | PharmD - NY Columbia BS - Harvard BS certified
Se connecter -
Ghislain Gackiere
Vice President Customer Excellence at Stryker
Se connecter -
Jean-François Oglaza
Senior Staff Engineer chez Stryker
Se connecter -
Patrice Acar
Service Delivery Manager chez J&J
Se connecter -
Vincent Joubert
Se connecter -
Julie Paris
Se connecter